Genitourinary syndrome of menopause – is the problem solved? 
State of the art 2018

Jacek Szymański; Kornelia Zaręba; Grzegorz Jakiel; Aneta Słabuszewska-Jóźwiak

doi:10.5114/pm.2018.81741

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

4/2018
vol. 17

Send email

Copy url:

abstract:

Review paper

Genitourinary syndrome of menopause – is the problem solved? State of the art 2018

Jacek Szymański

,

Kornelia Zaręba

,

Grzegorz Jakiel

,

Aneta Słabuszewska-Jóźwiak

Menopause Rev 2018; 17(4): 168-174

DOI: https://doi.org/10.5114/pm.2018.81741

Online publish date: 2018/12/31

View full text Get citation

PlumX metrics:

Vulvovaginal atrophy accompanied by lower urinary tract dysfunction related to low levels of estrogen and androgens is labeled as genitourinary syndrome of menopause (GSM). Although this condition affects most postmenopausal women worldwide, it seems to be underdiagnosed and undertreated. Women should be properly advised to choose an adequate treatment modality to improve their quality of life, sexual relationships and social activity. The aim of this article to is increase knowledge of GSM. The current treatment options, both hormonal and non-hormonal, are reviewed. Topical estrogen therapy still remains the gold standard, but the demand for individually tailored therapy is growing. New treatment modalities are continuously included in clinical practice. They should consider the whole personality of a woman as well as cultural and social factors. Further studies on GSM and on the effectiveness of various treatment options are necessary to achieve this purpose.

keywords:

Genitourinary syndrome of menopause – is the problem solved? State of the art 2018

Jacek Szymański , Kornelia Zaręba , Grzegorz Jakiel , Aneta Słabuszewska-Jóźwiak

menopause, vulvovaginal atrophy, androgens, estrogens, SERMs, laser, RF devices

Jacek Szymański

,

Kornelia Zaręba

,

Grzegorz Jakiel

,

Aneta Słabuszewska-Jóźwiak